Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.03 USD | +4.25% |
|
-9.41% | +12.43% |
06-24 | Immunome, Inc.(NasdaqCM:IMNM) added to S&P Biotechnology Select Industry Index | CI |
05-31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.43% | 721M | |
+16.49% | 122B | |
+21.73% | 115B | |
+23.26% | 26.64B | |
-21.81% | 19.91B | |
-16.80% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target